Ryman Healthcare launches $1bn equity raise, trading halted
Ryman Healthcare (NZX:RYM) has announced a significant NZ$1 billion equity raise to strengthen its financial position. The capital will be raised through a placement to institutional investors, targeting approximately NZ$313 million, and a pro-rata accelerated non-renounceable entitlement offer to existing shareholders, seeking around NZ$688 million. Trading in RYM equity and quoted debt securities has been halted by NZ RegCo prior to market pre-open today. According to the announcement, the offer is structured for investors in New Zealand and Australia, complying with relevant financial markets regulations. Ryman Healthcare confirms compliance with continuous disclosure and financial reporting obligations. The company asserts that the offer will not materially affect control of Ryman Healthcare.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
News Alerts
Get instant email alerts when Ryman Healthcare publishes news
Free account required • Unsubscribe anytime